Endologix, Inc. , developer and marketer of innovative treatments for aortic disorders, announced today the presentation of positive 3-year clinical data from the Ovation European Post Market Registry at the 2017 Leipzig Interventional Course in Leipzig, Germany. The results were presented by Patrick Peeters, MD, Chief, Department of Cardiovascular Surgery, Imelda Hospital, Bonheiden, Belgium and investigator for the study.